HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PF 3758309

a PAK4 p21-activated kinase inhibitor; structure in first source
Also Known As:
PF-3758309; PF3758309
Networked: 9 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hoeflich, Klaus P: 2 articles (05/2013 - 11/2012)
2. Jubb, Adrian M: 2 articles (05/2013 - 11/2012)
3. Pitts, Todd M: 2 articles (01/2013 - 01/2013)
4. Murray, Brion W: 2 articles (01/2013 - 05/2010)
5. Tan, Aik-Choon: 2 articles (01/2013 - 01/2013)
6. Eckhardt, S Gail: 2 articles (01/2013 - 01/2013)
7. Shin, Eun-Young: 1 article (05/2015)
8. Han, Sang-Bae: 1 article (05/2015)
9. Chung, Jin H: 1 article (05/2015)
10. You, Soon-Tae: 1 article (05/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)
3. Sarcoma (Soft Tissue Sarcoma)
4. Experimental Melanoma
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. P-Glycoprotein
2. Phosphotransferases (Kinase)
3. Histone Deacetylase Inhibitors
4. Propolis (Bee Bread)
5. Melanocyte-Stimulating Hormones (MSH)
6. Melanins (Melanin)
7. Adenosine Triphosphate (ATP)
8. artepillin C
9. romidepsin (FK228)
10. caffeic acid phenethyl ester

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)